Bayer Healthcare Pharmaceuticals – Strategy, SWOT and Corporate Finance Report
Summary

Bayer Healthcare Pharmaceuticals – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Bayer HealthCare Pharmaceuticals,(Bayer Healthcare or ‘the company’), a subsidiary of Bayer AG is involved in development and commercialization of drugs in cardiovascular and blood diseases, oncology, ophthalmology and women’s healthcare. The company offers cardiovascular and blood disorder treatment drugs, women healthcare products, contraceptives, erectile dysfunction medicines, testosterone deficiency treatment and ophthalmology products. It also offers oncology products, hematology drug, multiple sclerosis treatment drugs, diabetes treatment drugs, drugs for treatment of infectious diseases (respiratory tract infections, urinary-tract infections, serious skin infections), diagnostic imaging equipment and contrast agents. Bayer Pharma offers its products under brands such as Adalat, Adempas, Aleve, Adengo, Nebido, Xarelto, Xofigo, Yasmin, YAZ among others. It operates through its research and development facilities in Germany, France, China and the US. Bayer HealthCare is headquartered in Berlin, Germany.

Scope

- Detailed information on Bayer Healthcare Pharmaceuticals required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bayer Healthcare Pharmaceuticals in the form of a SWOT analysis
- An in-depth view of the business model of Bayer Healthcare Pharmaceuticals including a breakdown and examination of key business segments
- Intelligence on Bayer Healthcare Pharmaceuticals’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bayer Healthcare Pharmaceuticals, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Bayer Healthcare Pharmaceuticals and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bayer Healthcare Pharmaceuticals as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Bayer Healthcare Pharmaceuticals’s business structure, strategy and prospects.